2022
DOI: 10.1016/j.bas.2022.100860
|View full text |Cite
|
Sign up to set email alerts
|

Neurosurgery outcomes and complications in a monocentric 7-year patient registry

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
12
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
7

Relationship

1
6

Authors

Journals

citations
Cited by 13 publications
(17 citation statements)
references
References 51 publications
1
12
0
Order By: Relevance
“…18 In the past years, several grading systems such as the Landriel-Ibañez and Clavien-Dindo classification had been introduced for classifying postoperative complications in a standardized manner. 10,11,19 However, the Comprehensive Complication Index (CCI)…”
Section: Discussionmentioning
confidence: 99%
See 2 more Smart Citations
“…18 In the past years, several grading systems such as the Landriel-Ibañez and Clavien-Dindo classification had been introduced for classifying postoperative complications in a standardized manner. 10,11,19 However, the Comprehensive Complication Index (CCI)…”
Section: Discussionmentioning
confidence: 99%
“…Recently, reporting of postoperative complications as an outcome measure, classifying its severity, defining procedure-related risk factors, and proposals for reducing the frequency attached greater importance. 11,[20][21][22] These studies emphasized the potential implication of the Clavien-Dindo classification (CDC) as a standardized grading system for various neurosurgical procedures. According to the current literature, any adverse event graded as CD I or higher occurs in 13% to 58% of the cases, depending on the specific procedure and defined time interval.…”
Section: Accepted Manuscriptmentioning
confidence: 99%
See 1 more Smart Citation
“…We prospectively collected data from the patient registry of the Department of Neurosurgery at the University Hospital Zurich ( 5 ). We screened all patients with initial surgery for anaplastic astrocytoma (WHO grade III) or glioblastoma (WHO grade IV) for eligibility—between January 2013 and June 2017.…”
Section: Methodsmentioning
confidence: 99%
“…Perioperative adverse events (AEs) are an important and sensitive parameter in measuring management quality of the perioperative period (2,3). Importantly, AEs occur frequently during and after neurosurgical interventions and are associated with poor functional status (4)(5)(6).…”
Section: Introductionmentioning
confidence: 99%